NKGen Biotech, Inc. (NYSE:GFOR) filed a Form 8-K with the Securities and Exchange Commission on February 05, 2026, disclosing a material event.
NKGen Biotech, Inc.'s stock currently trades at $8.30 with a market capitalization of $86.1M. The Financial Services company's stock moved following the disclosure.